TBPH EBITDA
Theravance Biopharma Inc · EBITDA
TBPH EBITDA
Latest reported$68.68Mperiod ending
TBPH EBITDA (-$105.49M → $68.68M)
Annual EBITDA
High-resolution chart · PNG
TBPH ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 137,223,000 | |
| -38,453,000 | |
| -49,393,000 | |
| -72,095,000 | |
| -229,044,000 | |
| -287,824,000 | |
| -203,601,000 | |
| -212,437,000 | |
| -259,137,000 | |
| -176,036,000 | |
| -178,768,000 | |
| -228,012,000 | |
| -153,631,000 | |
| -6,324,000 | |
| -105,491,000 |